Literature DB >> 8654152

Time course of adaptive regulatory peptide changes following massive small bowel resection in the dog.

T E Adrian1, J S Thompson, E M Quigley.   

Abstract

Basal and postprandial concentrations of gastrointestinal hormones were measured in 12 dogs before and at one and three months after a 75% small bowel resection. Five animals were studied again at six months. Concentrations of enteric hormones and neuropeptides, measured in the proximal jejunum and distal ileum adjacent to the anastomotic site at the time of euthanasia, were compared with concentrations in control tissues taken from each animal at the time of resection. Increased basal and postprandial levels of gastrin (P < 0.05), cholecystokinin (CCK, P < 0.05), glucose-dependent insulinotropic peptide (GIP, P < 0.01), peptide YY (PYY, P < 0.001), and enteroglucagon (P < 0.001), were seen at one month after small bowel resection. In contrast, no significant changes were seen in concentrations of secretin, motilin, neurotensin, somatostatin, PP, or glucagon. Concentrations of enteroglucagon, GIP, and PYY remained high throughout the six-month study period. In contrast, gastrin and CCK had normalized by three months. Thus, only enteroglucagon, PYY, and GIP showed sustained elevations following enterectomy; the gastrin and CCK changes were transient. Following enterectomy, concentrations of vasoactive intestinal polypeptide (VIP) were reduced by about 50% in mucosal (P < 0.001) and muscle (P < 0.05) layers of proximal and distal gut. In contrast, calcitonin gene-related peptide (CGRP) was increased by about twofold in jejunal and ileal mucosa (P < 0.05), and CGRP elevations were even more marked in the muscle layers (P < 0.001). Somatostatin and neuropeptide Y (NPY) concentrations were similar to controls in all areas except for a small decrease in NPY in ileal mucosa (P < 0.05). These findings suggest that the increased motilin and PP concentrations previously reported after bowel resection in man are more likely to reflect underlying inflammatory bowel disease rather than enterectomy. The normalization of hypergastrinemia explains why the increased acid secretion after small bowel resection is transient. These results provide evidence for independent secretory control of enteroglucagon and PYY, which are both products of intestinal L cells. In addition, these studies reveal marked changes in enteric neuropeptide concentrations following bowel resection. VIP, which is thought to be a major inhibitory transmitter in the gut, is markedly reduced, while CGRP, which is mainly localized in sensory afferent fibers, is increased. These major neuropeptide changes are likely to be of importance in the adaptive responses to massive small bowel resection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8654152     DOI: 10.1007/bf02088237

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  52 in total

1.  RELATION OF MASSIVE BOWEL RESECTION TO GASTRIC SECRETION.

Authors:  P L FREDERICK; J S SIZER; M P OSBORNE
Journal:  N Engl J Med       Date:  1965-03-11       Impact factor: 91.245

2.  Functional compensation after small-bowel resection in man. Demonstration by direct measurement.

Authors:  R H Dowling; C C Booth
Journal:  Lancet       Date:  1966-07-16       Impact factor: 79.321

3.  Hypersecretion of gastrin associated with the short bowel syndrome.

Authors:  E Straus; C D Gerson; R S Yalow
Journal:  Gastroenterology       Date:  1974-02       Impact factor: 22.682

4.  An enteroglucagon tumour.

Authors:  S R Bloom
Journal:  Gut       Date:  1972-07       Impact factor: 23.059

5.  Nutrient-independent increases in proglucagon and ornithine decarboxylase messenger RNAs after jejunoileal resection.

Authors:  D B Rountree; M H Ulshen; S Selub; C R Fuller; S R Bloom; M A Ghatei; P K Lund
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

6.  Is peptide YY trophic to the intestinal epithelium of parenterally fed rats?

Authors:  R A Goodlad; M A Ghatei; J Domin; S R Bloom; N A Wright
Journal:  Digestion       Date:  1990       Impact factor: 3.216

7.  Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas.

Authors:  A Ali-Rachedi; I M Varndell; T E Adrian; D A Gapp; S Van Noorden; S R Bloom; J M Polak
Journal:  Histochemistry       Date:  1984

8.  Role of gastrointestinal hormones in the response to massive resection of the small bowel.

Authors:  A A D'sa; K D Buchanan
Journal:  Gut       Date:  1977-11       Impact factor: 23.059

9.  Peptide YY augments postprandial small intestinal absorption in the conscious dog.

Authors:  A J Bilchik; O J Hines; M J Zinner; T E Adrian; J J Berger; S W Ashley; D W McFadden
Journal:  Am J Surg       Date:  1994-06       Impact factor: 2.565

10.  Early regional expression and secretion of peptide YY and enteroglucagon after massive resection of small bowel.

Authors:  A J Bilchik; O J Hines; T E Adrian; M J Skotzko; D W McFadden; M J Zinner; S W Ashley
Journal:  J Am Coll Surg       Date:  1995-04       Impact factor: 6.113

View more
  6 in total

Review 1.  Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.

Authors:  G-R Martin; P-L Beck; D-L Sigalet
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

2.  Peptide YY Y1 receptor activates mitogen-activated protein kinase and proliferation in gut epithelial cells via the epidermal growth factor receptor.

Authors:  P J Mannon; J M Mele
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

3.  Neuroendocrine changes in colon of mice with a disrupted IL-2 gene.

Authors:  B F Qian; M El-Salhy; S Melgar; M L Hammarström; A Danielsson
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

4.  Factors affecting outcome following proximal and distal intestinal resection in the dog: an examination of the relative roles of mucosal adaptation, motility, luminal factors, and enteric peptides.

Authors:  J S Thompson; E M Quigley; T E Adrian
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

Review 5.  The role of peptide YY in gastrointestinal diseases and disorders (review).

Authors:  Magdy El-Salhy; Tarek Mazzawi; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  Int J Mol Med       Date:  2012-12-21       Impact factor: 4.101

6.  Role of the ileocecal junction in the motor response to intestinal resection.

Authors:  J S Thompson; E M Quigley; T E Adrian; F R Path
Journal:  J Gastrointest Surg       Date:  1998 Mar-Apr       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.